Company / FCF Margin
TherapeuticsMD, Inc. FCF Margin History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-2144.1%
FY2022
5-year range
-2144.1% / -338.7%
FY2018-FY2022
Trend
-533.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -533% YoY in FY2022, a notable deviation from the 7-year average annual change of -87%.
Based on SEC 10-K filings.
-2144.1% in FY2022 with a 5-year CAGR of -1750.8%.
Declined from -664.8% to -2144.1% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -1689.8pp
- 5-Year Change
- -1750.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, fcf margin decreased 533.0% year-over-year.
- Peak fcf margin was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -2144.1% | -533.0% |
| FY2021 | -338.7% | +49.0% |
| FY2020 | -664.8% | -46.3% |
| FY2019 | -454.3% | -26.5% |
| FY2018 | -359.3% | +8.6% |
| FY2017 | -393.2% | -29.7% |
| FY2016 | -303.1% | -27.8% |
| FY2015 | -237.1% | +29.3% |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026